XLV vs FXH

Both XLV and FXH are ETFs. XLV has a lower 5-year return than FXH (10.66% vs 10.98%). XLV has a lower expense ratio than FXH (0.13% vs 0.62%). Below is the comparison between XLV and FXH.

FXH XLV
Segment Equity: U.S. Health Care Equity: U.S. Health Care
Issuer First Trust State Street Global Advisors
Net Assets $1.79B $25.75B
Expense Ratio 0.62% 0.13%
Management Style passive (index-based) passive (index-based)
Dividend Yield 0.00% 2.25%
Underlying Index StrataQuant Health Care Index S&P Health Care Select Sector Index
YTD Return 19.89% 8.25%
1-Year Return 23.70% 14.12%
3-Year Return 14.62% 12.45%
5-Year Return 10.98% 10.66%
10-Year Return 15.33% 15.38%

XLV description

The Fund seeks to provide investment results that, before expenses, correspond generally to the price and yield performance of the Health Care Select Sector Index. Under normal market conditions, the fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the Index.

XLV performance & returns

YTD Return 8.25%
1-Month Return 2.30%
3-Month Return 2.37%
1-Year Return 14.12%
3-Year Return 12.45%
5-Year Return 10.66%
10-Year Return 15.38%
XLV expense ratio is 0.13%.

XLV holdings

Top 10 Holdings (51.64% of Total Assets)

Name Symbol % Assets
Johnson & Johnson JNJ 9.88%
UnitedHealth Group Inc UNH 7.47%
Merck & Co Inc MRK 5.29%
Pfizer Inc PFE 5.14%
Abbott Laboratories ABT 4.86%
Thermo Fisher Scientific Inc TMO 4.40%
AbbVie Inc ABBV 3.90%
Amgen Inc AMGN 3.75%
Medtronic PLC MDT 3.52%
Danaher Corp DHR 3.43%

Other relevant XLV comparisons

You may also want to check out the following XLV comparisons that investors often look for on Finny

Or use Finny Compare Wizard to create a comparison you’d like to see.

FXH description

The Fund seeks investment results that correspond generally to the price and yield (before the Funds fees and expenses) of an equity index called the StrataQuant Health Care Index. The Fund normally invests at least 90% of its net assets (including investment borrowings) in common stocks that comprise the Index.

FXH performance & returns

YTD Return 19.89%
1-Month Return 2.22%
3-Month Return 7.27%
1-Year Return 23.70%
3-Year Return 14.62%
5-Year Return 10.98%
10-Year Return 15.33%
FXH expense ratio is 0.62%.

FXH holdings

Top 10 Holdings (21.63% of Total Assets)

Name Symbol % Assets
Horizon Therapeutics PLC HZNP 2.60%
Charles River Laboratories International Inc CRL 2.41%
West Pharmaceutical Services Inc WST 2.25%
Universal Health Services Inc Class B UHS 2.14%
Seattle Genetics Inc SGEN 2.14%
Tandem Diabetes Care Inc TNDM 2.13%
Bio-Rad Laboratories Inc BIO 2.12%
Humana Inc HUM 1.98%
Biogen Inc BIIB 1.97%
Alexion Pharmaceuticals Inc ALXN 1.89%

Other relevant FXH comparisons

You may also want to check out the following FXH comparisons that investors often look for on Finny

    Or use Finny Compare Wizard to create a comparison you’d like to see.

    You can check out all comparisons Finny users have looked for here. Feel free to the browse the list and view the comparisons that are of an interest to you.

    7-day free trial: Get unlimited comparisons, and stock, ETF and mutual fund analyses for just $15 a month, without ads. Start a free trial. Go ad free!

    Follow Us